Evaluating Mongolia’s Sugar-Sweetened Beverage Tax: A Cost-Effectiveness Analysis
Applied Health Economics and Health Policy · 2026-11 · 24 (6) · 1069-1080
DOI: 10.1007/s40258-026-01070-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Health Economics and Health Policy, online erschienen am 10.09.2026. Verfasst von Nyamdavaa Byambadorj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Economics, Macquarie Business School, Macquarie University, Sydney, NSW, Australia. dibo.byambadorj@mq.edu.au. Hauptthemen laut MEDLINE: Taxes, Sugar-Sweetened Beverages. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Macquarie University.
Abstract (Originalsprache)
Background
Mongolia has approved a tax of 20% on sugar-sweetened beverages (SSBs) to take effect in 2027, yet while prior work has assessed potential health impacts, no peer-reviewed study has evaluated its cost-effectiveness.
Objective
This study evaluates the cost-effectiveness of Mongolia’s planned SSB tax by estimating its effect on health outcomes, healthcare costs, and changes in SSB consumption patterns.
Methods
Using a Markov cohort model, we project outcomes over 10-year, 20-year and lifetime horizons. The model incorporates changes in the prevalence of overweight and obesity, noncommunicable disease (NCD) incidence, and associated costs, with primary outcomes measured in disability-adjusted life years (DALYs) averted, and quality-adjusted life years (QALYs) gained. To improve precision, disease risk estimates are informed by biomarker data, such as blood sugar and lipid levels, minimizing reliance on self-reported health indicators.
Results
The ad valorem tax of 20% is projected to reduce consumption of SSBs by 31% through consumer price response alone. Accounting for additional calorie reductions from 20% industry reformulation, the combined effective reduction in SSB-related energy intake reaches approximately 45%. Across the three time horizons, the tax could avert 13, 260 and 2255 premature deaths; yield 2899, 14,362 and 33,613 QALYs; and avert US$6.13 million, US$30.34 million and US$71.02 million, respectively, in healthcare costs. From the healthcare perspective, the tax is cost-effective over 10 years (net cost US$1.77 million; incremental cost-effectiveness ratio (ICER) US$611.99/QALY) and becomes cost-saving within 20 years and over the lifetime horizon.
Conclusions
These findings support the implementation of the SSB tax as a strategy to reduce Mongolia’s NCD burden and generate long-term fiscal and health benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Economics, Macquarie Business School, Macquarie University, Sydney, NSW, Australia. dibo.byambadorj@mq.edu.au.
- Department of Economics, Macquarie Business School, Macquarie University, Sydney, NSW, Australia.
- Department of Family Medicine, School of Medicine, Mongolian National University of Medical Science, Ulaanbaatar, Mongolia.
Förderung
- Macquarie University
Zitieren
APA
Byambadorj, N., Best, R., Mandakh, U., & Sinha, K. (2026). Evaluating Mongolia’s Sugar-Sweetened Beverage Tax: A Cost-Effectiveness Analysis. Applied Health Economics and Health Policy, 24(6), 1069-1080. https://doi.org/10.1007/s40258-026-01070-2
Vancouver
Byambadorj N, Best R, Mandakh U, Sinha K. Evaluating Mongolia’s Sugar-Sweetened Beverage Tax: A Cost-Effectiveness Analysis. Applied Health Economics and Health Policy. 2026;24(6):1069-1080. doi:10.1007/s40258-026-01070-2
BibTeX
@article{Byambadorj2026,
author = {Byambadorj, Nyamdavaa and Best, Rohan and Mandakh, Undram and Sinha, Kompal},
title = {Evaluating Mongolia’s Sugar-Sweetened Beverage Tax: A Cost-Effectiveness Analysis},
journal = {Applied Health Economics and Health Policy},
year = {2026},
volume = {24},
number = {6},
pages = {1069--1080},
doi = {10.1007/s40258-026-01070-2}
}
EUVIMED